Steven Nadler Email

SVP and Head Discovery and Translational Research . Aro Biotherapeutics

Current Roles

Employees:
54
Revenue:
$4.2M
About
Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse set of diseases.
Aro Biotherapeutics Address
601 Walnut Street
Philadelphia, PA
United States
Aro Biotherapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.